Ayoxxa Biosystems (stylized in its logo as AYOXXA) is a biotechnology company founded in 2010 in Singapore, and headquartered in Germany. The company is known for developing protein chip capable of detecting at once multiple biomarkers, biomarker signatures (including markers for cancer, allergies, age related macular degeneration AMD, or infectious diseases) from a small biological sample. The protein chip yields large amounts of data, being primarily aimed for use in biomedical research in academia, clinic and industry.
Development of a Protein chip platform based on the Bead-based Arrays, named LUNARIS (TM) multiplexing technology
Multiplexing and Readout Services, Assay Development Services
ADDRESS:- Cologne, Germany
2.BASF Plant Science
The company genetically modified crops like maize, soy, cotton, canola, sugarcane, sugar beet and potatoes “for a more efficient agriculture”. Together with subsidiaries and partners, as well as in cooperation with universities and research institutions, BASF Plant Science is also developing new procedures and practices in genetic technology.
Genetically modified crops by BASF are sold and distributed through biotechnology companies like Monsanto, KWS Saat, Embrapa, or CTC (Centro de Tecnologia Canavieira).
Maize, soy, canola, and cotton
Sugarcane, sugar beet
ADDRESS:- Ludwigshafen, Germany.
Bayer AG (/ˈbeɪ.ər, ˈbaɪ.ər/; German: [ˈbaɪɐ]) is a German multinational pharmaceutical and life sciences company and one of the largest pharmaceutical companies in the world. Headquartered in Leverkusen, Bayer’s areas of business include human and veterinary pharmaceuticals; consumer healthcare products; agricultural chemicals, seeds and biotechnology products. The company is a component of the Euro Stoxx 50 stock market index. Werner Baumann has been CEO since 2016. In 1898 Bayer trademarked the name heroin for the drug diacetylmorphine and marketed it as a cough suppressant and non-addictive substitute for morphine until 1910. Bayer also introduced phenobarbital; prontosil, the first widely used antibiotic and the subject of the 1939 Nobel Prize in Medicine; the antibiotic Cipro (ciprofloxacin); and Yaz (drospirenone) birth control pills.
Veterinary drugs, diagnostic imaging, general and specialty medicines, women’s health products, over-the-counter drugs, (formerly) diabetes care, pesticides, seeds, plant biotechnology
ADDRESS:- Leverkusen, North Rhine-Westphalia, Germany
BIOBASE is an international bioinformatics company headquartered in Wolfenbüttel, Germany. The company focuses on the generation, maintenance, and licensing of databases in the field of molecular biology, and their related software platforms. The company was founded in 1997 as a spin-off from the German Research Centre for Biotechnology (GBF), Braunschweig, Germany, known today as the Helmholtz Research Centre for Infection Research. *The founders were scientists of the GBF Research Group Bioinformatics, headed at that time by Edgar Wingender. The company is now managed by Michael Tysiak (CEO/CFO) and Frank Schacherer (COO).
BIOBASE Knowledge Library, TRANSFAC, Proteome databases, ExPlain,
Knowledge process outsourcing, custom curation, ExPlain analysis
ADDRESS:-Wolfenbuettel, EU, Germany
Manufacturing Organization (CDMO) and technology provider with extensive expertise in cell line engineering, process development, and GMP manufacturing of biopharmaceuticals. Our proprietary technologies accelerate and advance the development of drug candidates – from their inception to industrial market-readiness. Whether you want to produce an antibody, a therapeutic enzyme, or a virus, ProBioGen is your trusted and highly experienced partner for development and manufacturing. Starting with unique cell lines and all the way to scalable production, our process is tailored to your individual requirements. Expect best-in-class efficiency and competitive timelines combined with excellent customer service. We commit to top results and transparency at every stage.
GMP Production Cell Lines
Virus Production Development
Biosimilars & Biobetters
ADDRESS:- Herbert-Bayer-Straße 8, 13086 Berlin, Germany
Phone:-+49 30 322935100
Biomax Informatics is a Munich-based software company specializing in research software for bioinformatics. Biomax was founded in 1997 and has its roots in the Munich Information Center for Protein Sequences (MIPS). The company’s customer base consists of companies and research organizations in the areas of drug discovery, diagnostics, fine chemicals, food and plant production. In addition to exclusive software tools, Biomax Informatics provides services and curated knowledge bases. In September 2007, Biomax Informatics acquired the Viscovery software business of the Austrian data mining specialist Eudaptics Software.
BioXM Knowledge Management Environment
BioRS Integration and Retrieval System
Pedant-Pro Sequence Analysis Suite
ADDRESS:- Martinsried, Munich, Germany
German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases. It develops pharmaceutical candidates based on messenger ribonucleic acid (mRNA) for use as individualized cancer immunotherapies, as vaccines against infectious diseases and as protein replacement therapies for rare diseases, and also engineered cell therapy, novel antibodies and small molecule immunomodulators as treatment options for cancer. The company has developed an mRNA-based human therapeutic for intravenous administration to bring individualized mRNA-based cancer immunotherapy to clinical trials and to establish its own manufacturing process.
ADDRESS:- Mainz, Rhineland-Palatinate, Germany
C.H. Boehringer Sohn AG & Ko. KG is the parent company of the Boehringer Ingelheim group, which was founded in 1885 by Albert Boehringer in Ingelheim am Rhein, Germany. As of 2018, Boehringer Ingelheim is one of the world’s largest pharmaceutical companies, and the largest private one. Headquartered in Ingelheim, it operates globally with 146 affiliates and more than 47,700 employees. Unlike most large pharmaceutical companies which are listed, the company is private and fully owned by the Boehringer, Liebrecht and von Baumbach families. The company’s key areas of interest are: respiratory diseases, metabolism, immunology, oncology and diseases of the central nervous system. Boehringer Ingelheim is a full member of the European Federation of Pharmaceutical Industries and Associations (EFPIA). The corporate logo of Boehringer Ingelheim depicts a stylized rendition of the central section of the imperial palace of Charlemagne.
Pharmaceuticals and Animal Health
ADDRESS:- Ingelheim, Germany
Computomics is a biotechnology company co-founded by Detlef Weigel and MEGAN author, Daniel Huson. Computomics provides bioinformatics data analysis services for plant breeding and metagenomics analyses for plant protection. Computomics was founded in October 2012 after the enormous decline in price of genome sequencing brought on by Next generation sequencing. Six scientists from the Max Planck Institute for Developmental Biology, Friedrich Miescher Laboratory of the Max Planck Society and University of Tübingen noted that plant genome sequencing was now tenable, but data analysis would remain a bottleneck. Computomics has been featured in several nationwide publications, because it is one of very few companies focusing on plant breeding and plant genome analysis.
Plant Breeding and Phenotyping
ADDRESS:- Tübingen, Germany
CureVac N.V. is a German biopharmaceutical company that develops therapies based on messenger RNA (mRNA). Legally domiciled in the Netherlands and headquartered in Tübingen, Germany, the company was founded in 2000 by Ingmar Hoerr (CEO), Steve Pascolo (CSO), Florian von der Mulbe (COO), Günther Jung and Hans-Georg Rammensee. CureVac had approximately 240 employees in November 2015 and 375 in May 2018.
The company’s focus is on developing vaccines for infectious diseases and drugs to treat cancer and rare diseases. CureVac has entered into various collaborations with organizations, including agreements with Boehringer Ingelheim, Sanofi Pasteur, Johnson & Johnson, Genmab, the Bill & Melinda Gates Foundation, Eli Lilly and Company, GlaxoSmithKline, Coalition for Epidemic Preparedness Innovations, the International AIDS Vaccine Initiative, and the government of Germany.
LIPID NANOPARTICLE (LNP)
CUREVAC CARRIER MOLECULE (CVCM)
MOLECULAR THERAPIES FOR RARE DISEASES
T +49 7071 9883 – 0
F +49 7071 9883 – 1101